Journal:
:international journal of endocrinology and metabolism
0
osamu saito department of nephrology, jichi medical university, simotsuke, 329-0498, japan +81-285587346, nephsait@jichi.ac.jp; department of nephrology, jichi medical university, simotsuke, 329-0498, japan +81-285587346, nephsait@jichi.ac.jp
takako saito department of nephrology, jichi medical university, simotsuke, 329-0498, japan +81-285587346, nephsait@jichi.ac.jp
shinji asakura oyama suginoki clinic, japan
tetsu akimoto department of nephrology, jichi medical university, simotsuke, 329-0498, japan +81-285587346, nephsait@jichi.ac.jp
makoto inoue department of nephrology, jichi medical university, simotsuke, 329-0498, japan +81-285587346, nephsait@jichi.ac.jp
yasuhiro ando department of nephrology, jichi medical university, simotsuke, 329-0498, japan +81-285587346, nephsait@jichi.ac.jp
background osteoporosis and chronic kidney disease are common conditions in older adults, and often occur concurrently. bone disease is caused by increased bone turnover accompanying secondary hyperparathyroidism, and by factors such as bone metabolic disorder accompanying kidney disease and postmenopausal or age-related osteoporosis, even in hemodialysis patients. raloxifene is commonly used f...